Placebo News and Research

RSS

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells, with less need for chemotherapy, following results of multiple landmark clinical trials reported for the first time in late-breaking presentations at the ESMO Congress 2023 (1-7).

17 Oct 2023

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Results from highly anticipated phase 3 clinical trials in gynecological cancers with, among others, new data that cover the entire spectrum of managing patients with cervical cancer, will be presented at the ESMO Congress 2023 in Madrid, Spain.

17 Oct 2023

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

New orally-administered GLP-1 receptor agonists danuglipron and orforglipron show promise in treating type 2 diabetes and obesity, according to a systematic review. While effective in glycemic control and weight reduction, these drugs come with gastrointestinal side effects that may lead to treatment discontinuation.

17 Oct 2023

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

In a groundbreaking 84-week-long study, researchers found that tirzepatide, a medication initially designed for treating type 2 diabetes, significantly bolstered weight loss in overweight and obese patients already on intensive lifestyle programs. While the drug showed promise in further reducing body weight and improving cardiometabolic factors, mild to moderate gastrointestinal side effects were the most common drawback.

16 Oct 2023

Can creatine and resistance training trim your body fat percentage?

Study reveals that resistance training combined with creatine supplementation effectively reduces body fat percentage in adults under 50 without affecting absolute fat mass. Findings are consistent across variables like age, BMI, and exercise frequency, suggesting a uniform impact.

16 Oct 2023

Widely available prescription drug can improve IBS symptoms

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today at UEG Week 2023 has found.

16 Oct 2023

Can herbal remedies, spices, and dietary fibers offer effective treatment options for children with irritable bowel syndrome (IBS)?

The positive effects and adverse reactions of spices, dietary fiber, and medicinal herbs for pediatric patients with IBS.

16 Oct 2023

Two simple solutions could help prevent postpartum hemorrhage

Two simple solutions could help prevent severe bleeding (postpartum hemorrhage) after cesarean delivery, suggests research presented at the ANESTHESIOLOGY® 2023 annual meeting.

15 Oct 2023

Shaking things up: Whole-body vibrations rev up metabolism in young men

This study found that repeated sessions of whole-body vibration significantly increased the resting metabolic rate in healthy young men. The results suggest potential applications of whole-body vibration in addressing metabolic health issues, such as obesity.

15 Oct 2023

Early intervention with sublingual immunotherapy may lead to remission of peanut allergy

A three-year clinical trial funded by the National Institutes of Health and Food Allergy Research and Education (FARE) has shown that the sublingual immunotherapy, or SLIT, is safe in peanut-allergic children ages 1 to 4, with a greater likelihood of desensitization and remission the earlier the treatment began.

13 Oct 2023

Ketogenic diets found to slash migraine frequency and fatigue in new study

Italian researchers find that ketogenic diets not only reduce the frequency and intensity of migraines but also significantly alleviate fatigue in sufferers. The study opens new doors for alternative, diet-based therapies for chronic and high-frequency episodic migraineurs.

12 Oct 2023

Ketamine shows complex influence on social cognition in schizophrenia, study reveals

Researchers from the University of Bonn delve into the complex relationship between ketamine and social cognition deficits in schizophrenia, revealing both promising and cautionary insights.

12 Oct 2023

New treatment option for hand osteoarthritis identified

Relief could be on the way for people with painful hand osteoarthritis after a Monash University and Alfred Health-led study found an affordable existing drug can help. Until now there has been no effective treatment.

12 Oct 2023

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

A new study will combine an Alzheimer's medication that slows disease progression in some patients with two other drugs to see if their effects can be amplified.

12 Oct 2023

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

The National Cancer Institute awarded investigators at Huntsman Cancer Institute a grant totaling more than $3 million to conduct a clinical trial to see if combining creatine monohydrate supplementation and resistance exercise training helps preserve muscle in people who have metastatic prostate cancer.

11 Oct 2023

Saline injection treatment for calcific tendinopathy provides no meaningful benefit over placebo

A saline injection treatment widely used for calcific tendinopathy - a common, painful condition caused by a build-up of calcium in the rotator cuff tendons of the shoulder - provides no meaningful benefit over placebo, concludes a trial published by The BMJ today.

11 Oct 2023

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

Western Sydney University's NICM Health Research Institute has led a world-first clinical trial in Australia that offers new hope in the treatment of mild cognitive impairment (MCI) among older people.

11 Oct 2023

A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy

The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults.

11 Oct 2023

Black Chokeberry (Aronia melanocarpa) diabetes benefits: Hope or hype?

Researchers compared the effects of fermented and non-fermented Aronia melanocarpa berries on glycemic markers in Type 2 Diabetes Mellitus patients. Despite the berries' high antioxidant potential and past studies suggesting benefits, this rigorous trial found no significant impact on waist circumference, insulin sensitivity, or glucose levels.

10 Oct 2023

New drug shows promise for epilepsy patients with resistant seizures

In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.

9 Oct 2023

Placebo News and Research

New treatment options offer hope for patients with non-small cell lung cancer

Late-breaking studies could change the treatment landscape for women with gynecological cancers

Oral diabetes and obesity meds danuglipron and orforglipron show promise but have gastrointestinal drawbacks

Tirzepatide boosts weight loss in lifestyle intervention patients, but comes with a catch

Can creatine and resistance training trim your body fat percentage?

Widely available prescription drug can improve IBS symptoms

Can herbal remedies, spices, and dietary fibers offer effective treatment options for children with irritable bowel syndrome (IBS)?

Two simple solutions could help prevent postpartum hemorrhage

Shaking things up: Whole-body vibrations rev up metabolism in young men

Early intervention with sublingual immunotherapy may lead to remission of peanut allergy

Ketogenic diets found to slash migraine frequency and fatigue in new study

Ketamine shows complex influence on social cognition in schizophrenia, study reveals

New treatment option for hand osteoarthritis identified

New Alzheimer's study to combine drugs targeting amyloid and tau proteins

Clinical trial tests creatine monohydrate and exercise to preserve muscle mass in prostate cancer patients

Saline injection treatment for calcific tendinopathy provides no meaningful benefit over placebo

World-first clinical trial offers new hope in the treatment of mild cognitive impairment among older people

A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy

Black Chokeberry (Aronia melanocarpa) diabetes benefits: Hope or hype?

New drug shows promise for epilepsy patients with resistant seizures

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News